Healthcare > Medical Devices & Equipment
•1093 stocks
•
Total Market Cap: Loading...
Mar 05, 2026
|
Mistras Group Reports Q4 2025 Earnings: Revenue Up 5.1%, Non‑GAAP EPS Beats Estimates, GAAP EPS Misses
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1093)
| Company | Market Cap | Price |
|---|---|---|
|
OFIX
Orthofix Medical Inc.
Broad investable theme capturing medical devices and biometric sensing products, aligning with Orthofix's medical device offerings.
|
$509.65M |
$12.55
-2.49%
|
|
BBNX
Beta Bionics, Inc.
Core product is a medical device (iLet Bionic Pancreas) and related biometrics in diabetes care.
|
$501.00M |
$11.01
-3.30%
|
|
MG
Mistras Group, Inc.
MG provides Laboratory Testing & Advisory Services as part of its inspection and testing offerings.
|
$494.52M |
$15.07
-3.86%
|
|
MYGN
Myriad Genetics, Inc.
Laboratory testing and advisory services; Myriad operates clinical labs delivering diagnostic tests.
|
$492.17M |
$5.18
-1.80%
|
|
CYH
Community Health Systems, Inc.
CYH directly provides hospital inpatient and outpatient care services through a network of hospitals and related facilities.
|
$475.12M |
$3.38
-1.31%
|
|
PACB
Pacific Biosciences of California, Inc.
PacBio directly manufactures diagnostic sequencing equipment (instruments) used in molecular diagnostics and research laboratories.
|
$470.98M |
$1.51
-2.88%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$470.48M |
$12.68
+1.85%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$464.64M |
$13.37
-4.19%
|
|
KIDS
OrthoPediatrics Corp.
Directly manufactures pediatric orthopedic implants and devices (plates, screws, growing rods, braces), the core product category for the company.
|
$463.36M |
$17.47
-5.47%
|
|
ANGO
AngioDynamics, Inc.
Core product category: vascular intervention devices, including Auryon, AlphaVac, and AngioVac.
|
$452.79M |
$10.85
-1.27%
|
|
FLGT
Fulgent Genetics, Inc.
Laboratory testing and advisory services.
|
$432.46M |
$14.13
+1.04%
|
|
CERS
Cerus Corporation
Cerus' INTERCEPT Blood System is a medical device platform; primary product is a device used in transfusion safety.
|
$430.28M |
$2.06
-8.26%
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
Laboratory Testing & Advisory Services aligns with CRO-type fee-for-service capabilities.
|
$405.35M |
$6.86
+2.47%
|
|
LAB
Standard BioTools Inc.
SomaScan laboratory testing and advisory services are a core direct offering.
|
$404.91M |
$1.03
-2.36%
|
|
KOPN
Kopin Corporation
CR3 medical headset and defense medical imaging/biometric sensing align with Medical Devices & Biometrics.
|
$377.71M |
$2.25
-2.80%
|
|
AUNA
Auna S.A.
AUNA operates hospitals and provides inpatient and outpatient care, i.e., hospital services.
|
$374.29M |
$5.00
-1.19%
|
|
NUS
Nu Skin Enterprises, Inc.
The Prysm iO and related wellness devices involve medical/biometric device technology.
|
$371.48M |
$7.67
+0.66%
|
|
TLSI
TriSalus Life Sciences, Inc.
TriNav and related systems are vascular intervention devices used for embolization and targeted drug delivery.
|
$370.02M |
$7.32
+0.48%
|
|
ORGO
Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
|
$364.24M |
$2.92
+1.57%
|
|
NVEC
NVE Corporation
Medical devices & biometrics applications, including implantable sensors and collaboration with Abbott.
|
$334.88M |
$68.03
-1.73%
|
|
NAUT
Nautilus Biotechnology, Inc.
The hardware/assay suite functions as diagnostic-type equipment for proteomics analyses.
|
$330.92M |
$2.46
-5.92%
|
|
RXST
RxSight, Inc.
RxSight's core offering is the Light Adjustable Lens system and related ophthalmic devices used in premium cataract surgery, which fits Ophthalmology Devices.
|
$326.05M |
$7.90
-0.38%
|
|
DCTH
Delcath Systems, Inc.
The company sells medical device technology (hepatic delivery system) and related procedures.
|
$325.95M |
$8.96
-2.87%
|
|
MTLS
Materialise N.V.
Materialise's Mimics platform centers on medical imaging analysis and planning workflows.
|
$311.28M |
$5.29
+0.38%
|
|
SMLR
Semler Scientific, Inc.
QuantaFlo is a diagnostic device used to measure arterial blood flow for PAD, directly constituting Diagnostic Equipment.
|
$300.98M |
$20.34
+0.02%
|
|
SCPH
scPharmaceuticals Inc.
Auto-Injector Devices reflect the SCP-111 autoinjector program for at-home administration.
|
$299.33M |
$5.67
|
|
SOPH
SOPHiA GENETICS S.A.
Liquid Biopsy: MSK-ACCESS application and liquid biopsy analytics integrated into the platform.
|
$286.65M |
$4.21
-0.36%
|
|
SY
So-Young International Inc.
Wuhan Miracle Laser integration indicates the company uses/markets medical devices and biometrics in aesthetics.
|
$286.05M |
$2.91
+1.04%
|
|
SGHT
Sight Sciences, Inc.
Directly manufactures ophthalmic surgical devices (OMNI Surgical System, TearCare-related tools) used in eye care, i.e., ophthalmology devices.
|
$283.31M |
$4.04
-25.23%
|
|
SENS
Senseonics Holdings, Inc.
Senseonics develops and markets implantable medical devices and biometric sensing technologies (Eversense CGM), fitting the Medical Devices & Biometrics investable theme.
|
$280.70M |
$6.30
-8.30%
|
|
QTRX
Quanterix Corporation
Quanterix directly manufactures and sells ultra-sensitive diagnostic instruments (Simoa platforms) used for biomarker detection in blood and other samples.
|
$273.73M |
$5.30
-9.56%
|
|
DDD
3D Systems Corporation
Offers dental equipment and dental 3D printing solutions (NextDent).
|
$268.05M |
$2.00
-4.31%
|
|
LFCR
Lifecore Biomedical, Inc.
New 5-head aseptic isolator filler expands capacity for filling into prefilled syringes.
|
$261.40M |
$6.79
-3.90%
|
|
CLPT
ClearPoint Neuro, Inc.
ClearPoint's core offerings include neurosurgical navigation hardware and related surgical equipment (e.g., ClearPoint system, Prism Laser Therapy, Velocity Alpha drill).
|
$254.14M |
$9.00
+0.67%
|
|
HBB
Hamilton Beach Brands Holding Company
Home health monitoring devices tied to HealthBeacon’s at-home patient monitoring platform and subscription model.
|
$252.73M |
$18.63
-0.90%
|
|
SPOK
Spok Holdings, Inc.
GenA alphanumeric pager represents a medical device hardware line under Medical Devices & Biometrics.
|
$252.33M |
$12.34
+0.69%
|
|
MPAA
Motorcar Parts of America, Inc.
MPAA markets and sells diagnostic equipment, such as the JBT-1 Bench Top tester.
|
$249.06M |
$13.04
+1.36%
|
|
MGRM
Monogram Orthopaedics, Inc.
Direct product category: Monogram's system is a surgical device used in operating rooms for orthopedic procedures.
|
$243.79M |
$6.00
|
|
BNR
Burning Rock Biotech Limited
Burning Rock's brPROPHET MRD and MCED products are ctDNA-based diagnostics delivered as a liquid biopsy test.
|
$236.69M |
$21.01
-4.41%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy is an implantable cardiac stimulation-based treatment for hypertension, aligning with Cardiology Devices.
|
$236.32M |
$4.38
+1.04%
|
|
SMTI
Sanara MedTech Inc.
bone fusion/orthopedic implants (BiFORM, ALLOCYTE Plus) and associated bone void filler (OsStic) place the company in Orthopedic Devices.
|
$230.66M |
$25.48
-1.66%
|
|
PROF
Profound Medical Corp.
Profound's flagship TULSA-PRO is a surgical device used for MR-guided prostate tissue ablation.
|
$224.80M |
$7.10
-5.08%
|
|
KRMD
KORU Medical Systems, Inc.
KRMD's core business is medical devices focused on patient-centric subcutaneous infusion systems (Freedom) and related components.
|
$224.24M |
$4.80
-1.03%
|
Showing page 6 of 11 (1093 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
